Literatur

[1] Perk J et al. European Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2012; 33: 1635–701

[2] Koenen RR. The prowess of platelets in immunity and inflammation. Thromb Haemost. 2016; 116: 605–12

[3] Cox D et al. Platelets and the innate immune system: mechanisms of bacterial-induced platelet activation. J Thromb Haemost. 2011; 9: 1097–107

[4] Suades R et al. Circulating and platelet-derived microparticles in human blood enhance thrombosis on atherosclerotic plaques. Thromb Haemost. 2012; 108: 1208–19

[5] Vasina EM et al. Microparticles from apoptotic platelets promote resident macrophage differentiation. Cell Death Dis. 2011; 2: e211

[6] Laffont B et al. Platelet microparticles reprogram macrophage gene expression and function. Thromb Haemost. 2016; 115: 311–23

[7] Sadallah S et al. Microparticles (ectosomes) shed by stored human platelets downregulate macrophages and modify the development of dendritic cells. Journal of Immunology. 2011; 186: 6543–52

[8] Laffont B et al. Activated platelets can deliver mRNA regulatory Ago2*microRNA complexes to endothelial cells via microparticles. Blood. 2013; 122: 253–61

[9] Vajen T et al. Platelet extracellular vesicles induce a pro-inflammatory smooth muscle cell phenotype. J Extracell Vesicles. 2017; 6: 1322454

[10] Giebel T. Verfahren zur Präparation von extrazellulären Vesikeln. Trillium Diagnostik 2017; 15: 102–3

[11] Nilsson R et al. Blood platelets contain tumor-derived RNA biomarkers. Blood. 2011; 118: 3680–3

[12] Znmigrodzka M et al. The biology of vesicles. Tumor Biol 2016; 37: 4391–401

zurück